Prognostic role of amenorrhea induced by adjuvant chemotherapy in premenopausal patients with early breast cancer.

由 Bianco, A. R., Del Mastro, L., Gallo, C., Perrone, F., Matano, E., Pagliarulo, C., De Placido, S.
出版 1991

1700P Perception and attitudes of Italian physicians towards the management of checkpoint inhibitors in oncology during COVID-19 outbreak: Results from a national survey

由 Tagliamento, M., Spagnolo, F., Poggio, F., Soldato, D., Conte, B., Ruelle, T., Barisione, E., De Maria, A., Del Mastro, L., Di Maio, M., Lambertini, M.
發表在 Ann Oncol (2020)

1740P Assessing the impact of COVID-19 outbreak on the attitudes and practice of Italian oncologists towards breast cancer care and related research activities

由 Poggio, F., Tagliamento, M., Di Maio, M., Martelli, V., De Maria, A., Barisione, E., Grosso, M., Boccardo, F., Pronzato, P., Del Mastro, L., Lambertini, M.
發表在 Ann Oncol (2020)

COVID-19 infection in cancer patients: what has been the contribution of Associazione Italiana Oncologia Medica (AIOM) to oncological care since the beginning of the first pandemic...

由 Silvestris, N., Di Maio, M., Russo, A., Chiari, R., De Giorgi, U., Del Mastro, L., Giuffrida, D., La Verde, N., Perrone, F., Tucci, M., Beretta, G.D., Cinieri, S.
發表在 ESMO Open (2021)

HER2 expression and efficacy of dose-dense anthracycline-containing adjuvant chemotherapy in breast cancer patients

由 Del Mastro, L, Bruzzi, P, Nicolò, G, Cavazzini, G, Contu, A, D'Amico, M, Lavarello, A, Testore, F, Castagneto, B, Aitini, E, Perdelli, L, Bighin, C, Rosso, R, Venturini, Marco
出版 2005

Plasma estrone sulfate concentrations and genetic variation at the CYP19A1 locus in postmenopausal women with early breast cancer treated with letrozole

由 Lunardi, G., Piccioli, P., Bruzzi, P., Notaro, R., Lastraioli, S., Serra, M., Marroni, P., Bighin, C., Mansutti, M., Puglisi, F., Porpiglia, M., Ponzone, R., Bisagni, G., Garrone, O., Cavazzini, G., Clavarezza, M., Del Mastro, L.
出版 2012

Body mass index and circulating oestrone sulphate in women treated with adjuvant letrozole

由 Sini, V, Lunardi, G, Cirillo, M, Turazza, M, Bighin, C, Giraudi, S, Levaggi, A, Piccioli, P, Bisagni, G, Gnoni, R, Stridi, G, Porpiglia, M, Picardo, E, Ponzone, R, Marenco, D, Mansutti, M, Puglisi, F, Del Mastro, L
出版 2014

Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a...

由 De Angelis, C., Bruzzese, D., Bernardo, A., Baldini, E., Leo, L., Fabi, A., Gamucci, T., De Placido, P., Poggio, F., Russo, S., Forestieri, V., Lauria, R., De Santo, I., Michelotti, A., Del Mastro, L., De Laurentiis, M., Giuliano, M., De Placido, S., Arpino, G.
發表在 ESMO Open (2021)

Corrigendum to ‘Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel an...

由 De Angelis, C., Bruzzese, D., Bernardo, A., Baldini, E., Leo, L., Fabi, A., Gamucci, T., De Placido, P., Poggio, F., Russo, S., Forestieri, V., Lauria, R., De Santo, I., Caputo, R., Cianniello, D., Michelotti, A., Del Mastro, L., De Laurentiis, M., Giuliano, M., De Placido, S., Arpino, G.
發表在 ESMO Open (2021)

T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational study

由 Schettini, F., Conte, B., Buono, G., De Placido, P., Parola, S., Griguolo, G., Fabi, A., Bighin, C., Riccardi, F., Cianniello, D., De Laurentiis, M., Puglisi, F., Pelizzari, G., Bonotto, M., Russo, S., Frassoldati, A., Pazzola, A., Montemurro, F., Lambertini, M., Guarneri, V., Cognetti, F., Locci, M., Generali, D., Conte, P., De Placido, S., Giuliano, M., Arpino, G., Del Mastro, L.
發表在 ESMO Open (2021)